Curocell Inc
372320
Company Profile
Business description
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.
Contact
11, Gukjegwahak 16-ro
Yuseong-gu
Daejeon34002
KORT: +82 428633698
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
109
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,794.00 | 23.80 | 0.27% |
| CAC 40 | 7,804.67 | 40.83 | 0.53% |
| DAX 40 | 24,276.48 | 184.86 | 0.77% |
| Dow JONES (US) | 42,427.74 | 91.90 | -0.22% |
| FTSE 100 | 8,801.29 | 14.27 | 0.16% |
| HKSE | 23,654.03 | 141.54 | 0.60% |
| NASDAQ | 19,460.49 | 61.53 | 0.32% |
| Nikkei 225 | 37,657.04 | 90.41 | -0.24% |
| NZX 50 Index | 12,521.21 | 26.50 | 0.21% |
| S&P 500 | 5,970.81 | 0.44 | 0.01% |
| S&P/ASX 200 | 8,565.40 | 23.60 | 0.28% |
| SSE Composite Index | 3,376.20 | 14.23 | 0.42% |